How COVID-19 drug developers can stay ahead of viral variants
BioCentury,
Product Development Identifying vulnerabilities and informing COVID-19 countermeasure design with genomic surveillance and in…
Product Development Identifying vulnerabilities and informing COVID-19 countermeasure design with genomic surveillance and in…
- Monday, August 24th, 2020 Print |Email The National Institutes of Health will conduct independent trials investigating the…
The pharmaceutical company that makes remdesivir - the only medication that has emergency authorization to fight COVID-19 …